Related Experiment Video
Updated: May 24, 2026

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
[Lyme disease with hepatitis and corticosteroids: a case report]
M Muslmani1, M Gilson, A Sudre
1Service de rhumatologie, hôpital Sud Échirolles, CHU de Grenoble, avenue Kimberley, 38130 Échirolles, France. mmuslmani@chu-grenoble.fr
This case study highlights a rare instance of Lyme disease (LD) causing significant liver inflammation. It also questions the role of corticosteroids in potentially worsening LD symptoms without antibiotics.
Area of Science:
- Infectious Diseases
- Hepatology
- Rheumatology
Background:
- Liver function test abnormalities are occasionally noted in Lyme disease (LD).
- Hepatitis directly attributed to LD infection is exceptionally rare in medical literature.
Observation:
- A 78-year-old male with a history of polymyalgia rheumatica (PMR) presented with fever, cholestasis, and cytolysis post-tick exposure.
- Symptoms progressed to meningoradiculitis and erythema migrans, confirming Stage 2 Lyme disease.
- Corticosteroids were reinstituted due to suspected PMR relapse, coinciding with disease progression.
Findings:
- The patient exhibited marked liver inflammation, prompting investigation for co-infection.
- The clinical presentation suggests a potential link between corticosteroid use and Lyme disease severity.
Implications:
- This case underscores the importance of considering Lyme disease hepatitis, though rare.
- It raises awareness about the potential risks of corticosteroid use in Lyme disease patients without concurrent antibiotic treatment.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pericarditis III: Medical Management
Myocarditis III: Medical Management
Graves' Disease I: Introduction
Rheumatic Heart Disease III: Medical Management